Tempus
Healthcare & Life Sci
Company overview
Tempus is a health technology company based in Chicago, Illinois. It specializes in precision medicine, using data and artificial intelligence. Its products include genome sequencing and precision medicine diagnostics, with a primary focus on oncology, or cancer.
Tempus was founded in 2015. It became a public company after an IPO on Nasdaq under the ticker TEM on June 14, 2024, and had approximately 3,800 employees by the end of 2025. Historically, the median salary is ~$150,000. Tempus is a top-tier H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- Chicago, United States